Chairman of the Board
Mr. Eberwein has over 25 years of Wall Street experience and is the Founder and CEO of Lone Star Value Management (“LSVM”), a U.S. investment advisory firm. Prior to founding LSVM in January 2013, Mr. Eberwein was a Portfolio Manager at Soros Fund Management from January 2009 to December 2011 and Viking Global Investors from March 2005 to September 2008. In April 2018, Mr. Eberwein became CEO of Hudson Global, Inc., a global recruitment company, and has been on the Board since May 2014. Previously, Mr. Eberwein served as Chairman of the Board for AMERI Holdings, Inc., an IT services company, from May 2015 until August 2018, ATRM Holdings, Inc., a modular building company, from January 2013 until September 2019, and Crossroads Systems, Inc., from April 2013 until May 2016. Mr. Eberwein also served as a director of The Goldfield Corporation from May 2012 until May 2013, On Track Innovations Ltd. from December 2012 until March 2014, and NTS, Inc. from December 2012 until its sale to a private equity firm was completed in June 2014. Mr. Eberwein served on the Board of Hope for New York, a 501(c)3 organization dedicated to serving the poor and marginalized in New York City from 2011 until 2014 where he was Treasurer and on the Executive Committee. Mr. Eberwein earned a MBA from The Wharton School, University of Pennsylvania and a BBA with High Honors from The University of Texas at Austin.
Mr. Cunnion has an extensive history of leadership roles at healthcare media and communication companies. Since September 2008, Mr. Cunnion has been Chief Executive Officer of Remedy Health Media, a privately held health media company. Prior to that, from January 2004 to December 2007, Mr. Cunnion was the President of privately held HealthTalk, leading provider of tools and information for chronically ill patients and caregivers. Mr. Cunnion successfully built this company and subsequently sold it to Revolution Health in December 2007. Subsequent to this sale, Mr. Cunnion took on the role of Executive Vice President of Revolution Health, where he oversaw revenue and sales strategy until Revolution Health merged with Everyday Health. Prior to HealthTalk, from December 1998 to December 2003, Mr. Cunnion held the role of Sr. Director, Consumer Marketing at WebMD, where he led consumer sales strategy, product development and advertising operations. Mr. Cunnion currently serves on the board of directors of FSAStore.com, an FSA e-commerce company, a post he has held since 2011. Mr. Cunnion earned a B.A. degree in English from Florida State University.
John W. Sayward is a career Health care and pharmaceutical executive. Most recently, he served as the CEO of Hera Pharmaceuticals Inc., a preclinical pharmaceutical business with a focus on cervical cancer. He was a Partner at Nippon Heart Hospital, LLC from September 2005 to January 2007 which was formed to build and manage cardiovascular care hospitals in Japan. From 2002 to 2005, Mr. Sayward was the Executive Vice President and CFO of LMA North America Inc., a medical device business focused on patient airway management. From 1996 to 2001, Mr. Sayward served as the Executive Vice President of Finance and CFO and Treasurer at SICOR Inc., and was elected to their Board of Directors in 1998. Previous to the above, he served in various management positions with Baxter Healthcare. He received a B.A. in History from Northwestern University in 1973 and a Master of Management from the Kellogg School of Management at Northwestern University in 1975.
Mr. Quain brings to the Digirad Board over 30 years of Wall Street experience in research, investment banking, and private equity. He is currently a Senior Advisor to The Carlyle Group, L.P., a private equity firm. He had previously held senior management positions at One Equity Partners, ACI Capital, and ABN Amro.
Mr. Quain is currently the Lead Director of Jason Incorporated (NASDAQ: JASN) and Board member of AstroNova, Inc. (NASDAQ: ALOT). He also serves as a member of the Audit and Nominating Committees and as the Chairman of the Compensation Committee of AstroNova. Previously, Mr. Quain served on the Boards of RBC Bearings Incorporated, Hardinge, Inc., Xerium Technologies, Inc., Magnetek, Inc., Tecumseh Products Company, DeCrane Aircraft Holdings, Inc., Handy & Harman, Heico Corporation, Mechanical Dynamics, Inc., and Titan International, Inc. He also served as the Chairman of the Board of Register.com.
Mr. Quain has a Bachelor of Science degree in electrical engineering from the University of Pennsylvania and a Master of Business Administration degree from Harvard University. He is also a Chartered Financial Analyst.
President, Chief Executive Officer and Director, Digirad Corporation
Matt Molchan has held a variety of increasing responsibility roles since he joined Digirad in May 2007 via the acquisition of Ultrascan, Inc., the southeast’s largest mobile ultrasound business. These roles include Chief Operating Officer of Digirad Ultrascan Solutions from May 2007 to January 2012, President of Digirad Imaging Solutions until January 2013, President of Digirad beginning January 2013, and most recently Chief Executive Officer of Digirad since July 2013.
Prior to joining Ultrascan, Inc., he held various executive level positions in business development, finance and operations at Somera, Inc. and Equifax, Inc. He holds a Bachelor of Science degree in Economics from the United States Air Force Academy and a Masters of Business Administration in Finance from the University of Southern California.
Subscribe to the Digirad Newsletter for the latest updates.
©2023 Digirad Health, Inc. All rights reserved.